Analyst Consensus ?
ConsensusHold52 ratings
Bullish2140.4%
Neutral2751.9%
Bearish47.7%
Regions Financial Corporation · RF · FY2026 Q1 · Calendar Q2 2026
Regions beats Q1 EPS, misses revenue as asset spreads tighten
Regions enters 2026 from a strong base: Q1 EPS beat consensus with 18% ROE, and the path to net interest income growth rests on 2% loan growth, declining deposit costs, and fixed-rate asset repricing into longer-duration securities. Management reaffirmed its net interest income and noninterest revenue outlook despite a modestly softer quarter. The bank is investing in AI and a new commercial lending system while returning capital through buybacks and dividends with CET1 near 10.4% on a pro forma basis. The central tension is margin: tighter asset spreads and competitive deposit pricing could restrain the net interest income expansion the thesis depends on, and the deliberate securities-duration extension — at a $40M realized loss — is a near-term trade-off for future yield.
Reported Before market openNYSEFinancial Services
$23.26B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.62
Consensus $0.60
EPS surprise
+3.9%
Reported versus consensus
Reported revenue
$1.87B
Consensus $1.91B
Revenue surprise
-2.2%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+0.8%
Event window
SPY move
+1.2%
Same window
Abnormal move
-0.5%
Stock minus SPY
Volume
1.0×
Versus trailing sessions
Subsequent drift
-5.2%
Up to 20 sessions
RFSPY benchmark
Ask FN2 about RF FY2026 Q1
Transcript, numbers and history already loaded
Why did RF rise 0.8% after beating EPS estimates in FY2026 Q1?What changed in RF's guidance and outlook in FY2026 Q1?Give me the bull and bear case for RF after FY2026 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Q1 EPS beat consensus by roughly 3.9% while revenue trailed by about 2.2%, as tighter asset spreads kept net interest margin slightly below expectations. Regions sold $900M of short-duration securities at a $40M loss to extend duration and improve yields. Despite the softer quarter, management maintained its net interest income and noninterest revenue guidance and its capital-return framework.
Guidance delta
Guidance maintained. Management reaffirmed net interest income and noninterest revenue growth for the year, with low single-digit loan growth expected, and said deposit cost declines plus fixed-rate asset repricing should drive margin expansion.
Key takeaways
- Q1 EPS of $0.62 beat estimates by roughly 3.9%, with ROE of 18%; revenue of $1.873B came in about 2.2% below consensus.
- Net interest margin slipped slightly on tighter asset spreads; management expects deposit cost declines and asset repricing to drive expansion.
- Loan growth of 2% and low-single-digit deposit growth supported net interest income.
- Wealth management (+9% YoY) and treasury management payments (+6%) offset a 2% decline in noninterest revenue.
- Capital remained strong (CET1 ~10.4% pro forma), supporting ongoing buybacks and dividends.
Management priorities
- Launch the commercial lending system and small-business digital origination platform in summer 2026.
- Pilot deposit conversion in Q3 2026, with full conversion slated for 2027.
- Continue hiring across commercial banking, wealth management, and branch networks.
- Extend the duration of newly purchased securities to improve yields.
- Maintain share repurchases and dividends while monitoring regulatory capital changes.
Follow RF with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$27.62Current
$18Low
$28.16Average
$36High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Sep 23, 2026 |
| Baird | Neutral | Underperform | Upgrade | Sep 18, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Sep 8, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 29, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 21, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Jul 20, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 20, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 7, 2026 |
| Wells Fargo | Underweight | Underweight | Maintain | Jul 6, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Jul 6, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Mar 30, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jan 5, 2026 |
| Stephens & Co. | Equal Weight | Overweight | Downgrade | Oct 14, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 22, 2025 |
| Compass Point | Buy | Buy | Maintain | Dec 10, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Oct 24, 2024 |
| Argus Research | Buy | Hold | Upgrade | Oct 24, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Oct 21, 2024 |
| B of A Securities | Neutral | Neutral | Maintain | Jul 22, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 3, 2024 |
| Odeon Capital | Hold | Buy | Downgrade | Nov 13, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Dec 1, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Nov 21, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 25, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 20, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jan 21, 2020 |
| Janney Capital | Buy | Neutral | Upgrade | Jan 21, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Nov 12, 2019 |
| Citi | Sell | Neutral | Downgrade | Oct 8, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jul 11, 2019 |
| Sandler O'Neill | Buy | Hold | Upgrade | Mar 25, 2019 |
| B. Riley FBR | Neutral | Neutral | Maintain | May 5, 2018 |
| B. Riley Securities | Neutral | Neutral | Maintain | Apr 24, 2018 |
| FBR Capital | Neutral | Buy | Downgrade | Oct 10, 2017 |
| Susquehanna | Neutral | Positive | Downgrade | Dec 1, 2016 |
| PiperJaffray | Neutral | Overweight | Downgrade | Nov 16, 2016 |
| Bernstein | Market Perform | Outperform | Downgrade | Aug 16, 2016 |
| Keefe Bruyette & Woods | Market Perform | Underperform | Upgrade | Jun 6, 2016 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 1, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Oct 8, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Oct 8, 2015 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 28, 2015 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jan 21, 2015 |
| Wunderlich | Hold | Buy | Downgrade | Jan 21, 2015 |
| Miller Tabak | Buy | Hold | Upgrade | Aug 8, 2014 |
| ISI Group | Buy | Buy | Maintain | Oct 7, 2013 |
| Sandler O'Neil | Buy | Hold | Upgrade | Mar 6, 2013 |
| Rafferty Capital | Buy | Buy | Maintain | Feb 28, 2013 |
| Drexel Hamilton | Hold | Hold | Maintain | Oct 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $27.62. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $31 | $27.6 | +12.2% | Sep 23, 2026 |
| Morgan Stanley | Analyst unavailable | $36 | $30.42 | +30.3% | Sep 8, 2026 |
| Deutsche Bank | Analyst unavailable | $34 | $30.7 | +23.1% | Aug 27, 2026 |
| Cantor Fitzgerald | Dave Rochester | $35 | $31.11 | +26.7% | Jul 21, 2026 |
| Truist Financial | Analyst unavailable | $34 | $31.11 | +23.1% | Jul 21, 2026 |
| D.A. Davidson | Analyst unavailable | $34 | $31.3 | +23.1% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $34 | $31.65 | +23.1% | Jul 20, 2026 |
| Jefferies | David Chiaverini | $32 | $31.65 | +15.9% | Jul 17, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $34 | $30.92 | +23.1% | Jul 15, 2026 |
| Evercore ISI | Analyst unavailable | $31 | $30.36 | +12.2% | Jul 6, 2026 |
| D.A. Davidson | Analyst unavailable | $33 | $30.28 | +19.5% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $28 | $30.28 | +1.4% | Jul 6, 2026 |
| Morgan Stanley | Analyst unavailable | $35 | $30.16 | +26.7% | Jun 29, 2026 |
| Truist Financial | Analyst unavailable | $30 | $28.41 | +8.6% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $31 | $28.38 | +12.2% | Apr 20, 2026 |
| D.A. Davidson | Analyst unavailable | $32 | $28.13 | +15.9% | Apr 20, 2026 |
| UBS | Analyst unavailable | $30 | $30.48 | +8.6% | Feb 4, 2026 |
| Piper Sandler | Analyst unavailable | $31 | $27.77 | +12.2% | Jan 20, 2026 |
| Morgan Stanley | Analyst unavailable | $31 | $27.77 | +12.2% | Jan 19, 2026 |
| Wells Fargo | Analyst unavailable | $30 | $28.52 | +8.6% | Jan 16, 2026 |
| Goldman Sachs | Analyst unavailable | $32 | $28.18 | +15.9% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $30 | $27.56 | +8.6% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $29 | $27.78 | +5.0% | Dec 22, 2025 |
| Stephens | Analyst unavailable | $27 | $24.56 | -2.2% | Oct 14, 2025 |
| Evercore ISI | John Pancari | $29 | $26.5 | +5.0% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $32 | $26.63 | +15.9% | Sep 29, 2025 |
| Cantor Fitzgerald | Dave Rochester | $30 | $26.82 | +8.6% | Sep 9, 2025 |
| Barclays | Jason Goldberg | $27 | $26.24 | -2.2% | Jul 21, 2025 |
| Stephens | Terry McEvoy | $26 | $24.08 | -5.9% | Oct 29, 2024 |
| Argus Research | Kevin Heal | $26 | $23.78 | -5.9% | Oct 24, 2024 |
| Deutsche Bank | Matt O'Connor | $26 | $23.64 | -5.9% | Oct 24, 2024 |
| Truist Financial | Brandon King | $26 | $23.82 | -5.9% | Oct 21, 2024 |
| D.A. Davidson | Peter Winter | $29 | $23.82 | +5.0% | Oct 21, 2024 |
| Evercore ISI | John Pancari | $26 | $22.54 | -5.9% | Oct 2, 2024 |
| Wedbush | David Chiaverini | $28 | $22.91 | +1.4% | Sep 24, 2024 |
| Citigroup | Keith Horowitz | $26 | $22.72 | -5.9% | Sep 19, 2024 |
| Piper Sandler | Scott Siefers | $23 | $23.07 | -16.7% | Sep 3, 2024 |
| Morgan Stanley | Betsy Graseck | $28 | $22.43 | +1.4% | Jul 30, 2024 |
| D.A. Davidson | Peter Winter | $26 | $22.39 | -5.9% | Jul 22, 2024 |
| Truist Financial | Brandon King | $23 | $22.39 | -16.7% | Jul 22, 2024 |
| Robert W. Baird | David George | $21 | $22.09 | -24.0% | Jul 22, 2024 |
| RBC Capital | Gerard Cassidy | $23 | $22.09 | -16.7% | Jul 22, 2024 |
| Wells Fargo | Mike Mayo | $22 | $22.09 | -20.3% | Jul 21, 2024 |
| Jefferies | Ken Usdin | $24 | $20.09 | -13.1% | Jul 3, 2024 |
| UBS | Erika Najarian | $22 | $20.51 | -20.3% | Apr 4, 2024 |
| Piper Sandler | Scott Siefers | $15 | $14.1 | -45.7% | Oct 25, 2023 |
| Barclays | Analyst unavailable | $29 | $21.92 | +5.0% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $25 | $20.71 | -9.5% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $28 | $20.4 | +1.4% | Dec 16, 2022 |
| Jefferies | Ken Usdin | $22 | $18.92 | -20.3% | Jul 11, 2022 |
| UBS | Erika Najarian | $32 | $24.59 | +15.9% | Jan 12, 2022 |
| Evercore ISI | John Pancari | $27 | $23.88 | -2.2% | Nov 16, 2021 |
| Odeon Capital Group LLC | Richard Bove | $27.7 | $23.8 | +0.3% | Nov 10, 2021 |
| Piper Sandler | Stephen Scouten | $28 | $23.85 | +1.4% | Oct 25, 2021 |
| Wells Fargo | Mike Mayo | $24 | $21.49 | -13.1% | Oct 4, 2021 |
| KBW | David Konrad | $18 | $19.12 | -34.8% | Jul 6, 2021 |
| Compass Point | Dave Rochester | $25 | $22.19 | -9.5% | May 18, 2021 |
Track every rating change on RF the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationRegions Financial Corporation (RF) operates as a financial holding company, delivering a comprehensive array of banking and related services to both individual consumers and corporate entities. The firm's operations are strategically divided into three principal divisions: Corporate Bank, Consumer Bank, and Wealth Management. The Corporate Bank segment specializes in commercial banking solutions. Its extensive offerings include various lending options such as commercial and industrial loans, commercial real estate financing, and investor real estate credit. Furthermore, it provides equipment lease financing, manages diverse deposit products, and offers sophisticated capital markets services like securities underwriting and placement, loan syndication, foreign exchange, derivatives, and merger and acquisition advisory, along with other consulting services. This segment primarily serves corporate clients, middle-market businesses, and developers and investors in commercial real estate.…
Historical context
All RF earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
Get the RF recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-25T20:11:15.067111+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-25T20:11:15.063197+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-25. For educational purposes only; not investment advice.